Pamela Allen
Academic Appointment
- Associate Professor, Department of Hematology and Medical Oncology, Emory University School of Medicine
Education
Degrees
- MSc from Northwestern University, Chicago
- MD from University of Florida, Gainesville
Research
Publications
-
Efficacy and Safety of Denileukin Diftitox-Cxdl, an Improved Purity Formulation of Denileukin Diftitox, in Patients With Relapsed or Refractory Cutaneous T-Cell Lymphoma.
J Clin Oncol Volume: 43 Page(s): 1198 - 1209
04/01/2025 Authors: Foss FM; Kim YH; Prince HM; Akilov OE; Querfeld C; Seminario-Vidal L; Fisher DC; Kuzel TM; Yannakou CK; Geskin LJ -
Advances in Novel Systemic Therapies for the Management of Cutaneous T Cell Lymphoma (CTCL).
Curr Hematol Malig Rep Volume: 20 Page(s): 5
01/13/2025 Authors: Case KB; Allen PB -
The CNS relapse in T-cell lymphoma index predicts CNS relapse in patients with T- and NK-cell lymphomas.
Blood Adv Volume: 8 Page(s): 3507 - 3518
07/09/2024 Authors: Bhansali RS; Ellin F; Relander T; Cao M; Li W; Long Q; Ganesan N; Stuver R; Horwitz SM; Wudhikarn K -
Subsequent malignant neoplasms in patients previously treated with anti-CD19 CAR T-cell therapy.
Blood Adv Volume: 8 Page(s): 2327 - 2331
05/28/2024 Authors: Melody M; Epperla N; Shouse G; Romancik J; Allen P; Moyo TK; Kenkre V; Ollila T; Fitzgerald L; Hess B -
Impact of cumulative dose of brentuximab vedotin on outcomes of frontline therapy for advanced-stage Hodgkin lymphoma.
Blood Adv Volume: 7 Page(s): 7485 - 7493
12/26/2023 Authors: Steiner RE; Hwang SR; Khurana A; Habermann TM; Epperla N; Annunzio K; Allen PB; Baird K; Paulino D; Alderuccio JP -
Cutaneous T-cell lymphoma with CNS involvement: a case series and review of the literature.
CNS Oncol Volume: 12 Page(s): CNS105
12/01/2023 Authors: Preston JD; Jansen CS; Kosaraju S; Niyogusaba T; Zhuang TZ; Iwamoto SW; Hutto SK; Lechowicz MJ; Allen PB -
Sequential pembrolizumab and AVD are highly effective at any PD-L1 expression level in untreated Hodgkin lymphoma.
Blood Adv Volume: 7 Page(s): 2670 - 2676
06/27/2023 Authors: Allen PB; Lu X; Chen Q; O'Shea K; Chmiel JS; Slonim LB; Sukhanova M; Savas H; Evens AM; Advani R -
Low neutralizing activity of AZD7442 against current SARS-CoV-2 Omicron variants in patients with B-cell malignancies.
Blood Adv Volume: 7 Page(s): 2459 - 2462
06/13/2023 Authors: Chang A; Koff JL; Lai L; Orellana-Noia VM; Surati M; Leal AMK; Ellis ML; Wali B; Moreno A; Linderman SL -
Mitigation strategies among cutaneous T-cell lymphoma patients with positive Staphylococcus aureus skin and soft tissue cultures have unclear impacts on the risk of subsequent bacteremia.
Leuk Lymphoma Volume: 64 Page(s): 597 - 604
03/01/2023 Authors: Allen PB; Goyal S; Switchenko J; Tarabadkar E; Pouch S; Parikh P; Palmer A; Martini D; Kim E; Lechowicz MJ -
Staging lymph nodes and blood at diagnosis in mycosis fungoides identifies patients at increased risk of progression to advanced stage: A retrospective cohort study.
Cancer Volume: 129 Page(s): 541 - 550
02/15/2023 Authors: Allen PB; McCook-Veal AA; Switchenko JM; Paulino DM; Niyogusaba T; Baird KM; Tarabadkar ES; Lechowicz MJ